Top Stories

Meredith Corp. (MDP) said Wednesday that it has decided to explore the sale of its Time, Sports Illustrated, Fortune, and Money brands. In addition, the company will cut 1,000 jobs over the next ten months as part of its plan to realize cost synergies...

Brazilian power company Eletropaulo received a proposal from Enel Brasil for the 17% stake indirectly held by AES Corporation in the company and regarding Enel's participation in a potential share offer. In a statement, Eletropaulo said that "there...


After previously indicating he was considering vetoing the legislation, President Donald Trump revealed Friday he has signed a $1.3 trillion government spending bill. Trump said he signed the spending bill as "a matter of national security" even though...


Stocks saw considerable volatility during the trading session on Friday before ending the day sharply lower. The Dow tumbled to a nearly four-month closing low, while the Nasdaq and the S&P 500 fell to their lowest closing levels in well over a month. The...


Sex and the City star Cynthia Nixon has launched her campaign for New York governor with a stop in Brownsville, one of Brooklyn's most run-down neighbourhoods. The 51 year old New Yorker and progressive activist plans to challenge incumbent Governor...

qualcomm-pauljacobs-031618.jpg Qualcomm Inc. (QCOM) announced that Paul Jacobs will not be re-nominated to its board of directors at its Annual Meeting of Stockholders on March 23, 2018, following his decision to explore the possibility of making a proposal to acquire the company. Qualcomm said its board will of course evaluate, if Jacobs makes a proposal, consistent with its fiduciary duties to shareholders.
calendar-pharma-031618.jpg Another week has rolled by, and as usual, the biotech sector saw some stocks soaring to the moon and some hitting the skids. Let's take a look at the pharma stocks and upcoming events to keep an ear out for in the coming week.
asian-markets1_18mar18.jpg Asian stock markets are mostly lower on Monday despite the positive cues from Wall Street on Friday, with investors treading cautiously ahead of the U.S. Federal Reserve's highly anticipated monetary policy decision due later in the week. While the Fed is widely expected to raise interest rates by 25 basis points, new Fed Chairman Jerome Powell's first press conference may also attract attention.
stocksubdued-031918.jpg European stocks may open flat to slightly lower on Monday as cautious undertone may prevail ahead of the FOMC decision and Chairman Jerome Powell's news conference on Wednesday as well as the Bank of England's interest-rate decision on Thursday. While...
Read More
donaldtrump2-032318.jpg After previously indicating he was considering vetoing the legislation, President Donald Trump revealed Friday he has signed a $1.3 trillion government spending bill. Trump said he signed the spending bill as "a matter of national security" even though he was not happy with some of the elements of the legislation.
Read More
Graphene, a form of carbon, which was discovered in 2004, is said to have the potential for use in a variety of applications, say in the fields of electricity, conductivity, energy generation and storage, sensors, batteries, and many more. Now, researchers have identified a new use for this material - making better hair dyes.
Read More
The Swiss stock market dropped again Friday and ended the week in negative territory. After a weak start, the market staged a recovery in the early afternoon. However, retreated again ahead of the weekend. Trade war concerns sent investors fleeing to safe havens at the end of the trading week, after...
A new survey has found that university students in the United States are using money from their student loans to buy crypto currencies such as Bitcoin. An online survey was conducted by Pollfish for The Student Loan Report, a website that reports on students' debt issues, among 1,000 students. They were asked if they had ever used student loan money to invest in cryptocurrencies like Bitcoin. Read More
Today's Daily Dose brings you news about approval of Amicus Fabry disease drug in Japan; commercial launch of La Jolla's GIAPREZA in the U.S.; Emergent Bio's stock repurchase program; better-than expected quarterly financial results of HTG Molecular Diagnostics; FDA postponing the decision date on Progenics' AZEDRA, and reverse stock split of Ritter. Read More
GlaxoSmithKline plc (GSK, GSK.L) announced Friday that Shingrix has been approved in Europe and Japan for the prevention of shingles in adults aged 50 and over. The European Commission has approved Shingrix for the prevention of shingles (herpes zoster)... Read More
China has approved the removal of term limits for its leader, in a move that effectively allows Xi Jinping to remain as president for life. The constitutional changes were passed by China's annual sitting of the National People's Congress on Sunday. "As...
Read More
Follow RTT
Economic Calendar
03/23/18 13:0Baker Hughes - Rig CountMAR 23 United States
03/23/18 10:0New Home Sales - UnitsFEB United States
03/23/18 10:0New Home Sales - Median PricesFEB United States
03/23/18 9:0CB Coincidence IndexFEB China
03/23/18 9:0CB Leading IndexFEB China
03/23/18 8:30CPI (M-o-M)FEB Canada
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
06/16/18TEVAFremanezumab (BLA)FDA decision on Fremanezumab for the treatment of migraine
05/26/18REPHIV Meloxicam (NDA)FDA decision on IV Meloxicam for the management of moderate to severe pain
05/21/18DOVAAvatrombopag (NDA)FDA decision on Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease
05/17/18AMGNAimovig (BLA)FDA decision on Aimovig for the prevention of migraine
05/13/18VRX, VRX.TOPLENVU (NDA)FDA decision on PLENVU for cleansing of the colon in preparation of colonoscopy
View All